24,421 reports of this reaction
9.0% of all Repatha reports
#2 most reported adverse reaction
DRUG DOSE OMISSION BY DEVICE is the #2 most commonly reported adverse reaction for Repatha, manufactured by Amgen USA Inc.. There are 24,421 FDA adverse event reports linking Repatha to DRUG DOSE OMISSION BY DEVICE. This represents approximately 9.0% of all 269,908 adverse event reports for this drug.
Patients taking Repatha who experience drug dose omission by device should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG DOSE OMISSION BY DEVICE is moderately reported among Repatha users, representing a notable but not dominant share of adverse events.
In addition to drug dose omission by device, the following adverse reactions have been reported for Repatha:
The following drugs have also been linked to drug dose omission by device in FDA adverse event reports:
DRUG DOSE OMISSION BY DEVICE has been reported as an adverse event in 24,421 FDA reports for Repatha. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG DOSE OMISSION BY DEVICE accounts for approximately 9.0% of all adverse event reports for Repatha, making it one of the most commonly reported side effect.
If you experience drug dose omission by device while taking Repatha, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.